| 发明名称 |
Combinations of an anti-her2 antibody-drug conjugate and chemotherapeutic agents, and methods of use |
| 摘要 |
Disclosed is a therapeutic combination for the treatment of hyperproliferative disorders/breast cancer, comprising trastuzumab-MCC-DM1 and lapatinib, wherein the combination of the two provides a synergistic effect |
| 申请公布号 |
NZ709293(A) |
申请公布日期 |
2017.01.27 |
| 申请号 |
NZ20090709293 |
申请日期 |
2009.03.10 |
| 申请人 |
GENENTECH INC |
发明人 |
Sliwkowski Mark X;Berry Leanne;Phillips Gail Lewis |
| 分类号 |
A61K31/337;A61K31/416;A61K31/513;A61K31/517;A61K31/5355;A61K31/555;A61K39/395;A61K45/06;A61P35/00 |
主分类号 |
A61K31/337 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
